Medical Devices Outlook, 2025

Product Innovation and Investments to Drive Transformational Growth

The global medical devices industry was valued at $545.38 billion in 2024 and is expected to reach $801.34 billion in 2029. Companies continue to focus on and invest in new product development to ensure long-term and sustained growth. The cardiovascular devices market attracted significant investments, especially in transcatheter technologies for mitral and tricuspid valves, pulsed field ablation, and bioresorbable scaffolds.

Key market segments, including cardiovascular devices, diabetes care devices, robotics, and clinical-grade wearables, posted double-digit growth on a significantly higher revenue base, while neurology and respiratory devices posted high single-digit growth. Major geographic regions, including North America, Europe, and Asia-Pacific, registered high single-digit growth.

The study period for this analysis is 2022-2029 and the base year is 2024. Some important practice areas include patient monitoring, diabetes care, orthopedic devices, minimally invasive surgeries, ophthalmology, cardiovascular devices, wound care, respiratory, audiology, clinical-grade wearables, neurology, and robotics and navigation systems.

Top predictions for 2025 include the expanding use of clinical-grade wearables across various care settings, surgical robotic companies broadening their applications to enhance growth in precision medicine, improve accessibility, and boost patient outcomes, and AI-enabled predictive maintenance becoming a standard in the medical device servicing market.